GO:0016832 aldehyde-lyase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016832 aldehyde-lyase activity describes enzymes that cleave a C-C bond in a substrate containing both a hydroxyl group and a carbonyl group, producing two smaller aldehyde or ketone products [1,4,8].
• The term is synonymous with aldolase activity and is classified as a molecular_function in the Gene Ontology [1,4].
• Representative enzymes include steroid 17alpha-hydroxylase/17,20-lyase (CYP17A1), sphingosine-1-phosphate lyase (SGPL1), hydroperoxide lyase, and hydroxynitrile lyase [1,2,4,8].
• Aldehyde-lyase reactions are central to steroid hormone biosynthesis, sphingolipid metabolism, plant oxylipin/volatile aldehyde production, and cyanogenesis [1,2,4,8].
• Defects in aldehyde-lyase enzymes cause human disorders such as 17alpha-hydroxylase/17,20-lyase deficiency and sphingosine phosphate lyase insufficiency syndrome [1,2].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of aldehyde-lyase genes in disease and biotechnology [2,3,5,6].
Description
GO:0016832 aldehyde-lyase activity is a Gene Ontology molecular_function term that defines catalysis of the cleavage of a C-C bond in a molecule containing a hydroxyl group and a carbonyl group to form two smaller molecules, each being an aldehyde or a ketone [1,4,8]. This activity is widely distributed across steroidogenic, sphingolipid, plant oxylipin, and cyanogenic pathways, and it is often referred to as aldolase activity [1,2,4,8]. Researchers study aldehyde-lyases because they control the production of potent signaling lipids, steroid hormones, and volatile aldehydes, and because their dysfunction is linked to endocrine and immunological disease [1,2,5,6]. The term is experimentally supported by biochemical, genetic, and structural studies of enzymes such as CYP17A1, SGPL1, hydroperoxide lyase, and hydroxynitrile lyase [1,2,4,8]. Understanding GO:0016832 therefore connects enzyme mechanism to physiology, disease, and biotechnology [1,2,4,8].
aldehyde-lyase activity At A Glance
| GO ID | GO:0016832 |
|---|---|
| GO term | aldehyde-lyase activity |
| Ontology | molecular_function |
| Synonym | aldolase activity |
| Definition | Catalysis of the cleavage of a C-C bond in a molecule containing a hydroxyl group and a carbonyl group to form two smaller molecules, each being an aldehyde or a ketone. |
| Major function | Carbon-carbon bond cleavage in hydroxylated carbonyl substrates to yield aldehyde or ketone products. |
| Representative enzymes | CYP17A1, SGPL1, hydroperoxide lyase, hydroxynitrile lyase. |
| Pathway contexts | Steroid hormone biosynthesis, sphingolipid metabolism, plant oxylipin/volatile aldehyde production, cyanogenesis. |
| Disease relevance | 17alpha-hydroxylase/17,20-lyase deficiency; sphingosine phosphate lyase insufficiency syndrome. |
What Is GO:0016832?
In our own words, GO:0016832 aldehyde-lyase activity is the catalytic function of an enzyme that breaks a carbon-carbon bond in a substrate that carries both a hydroxyl group and a carbonyl group, generating two smaller molecules that are aldehydes or ketones [1,4,8]. This definition captures a carbon-carbon lyase reaction rather than a simple hydrolysis or oxidation, and it is the basis for the synonym aldolase activity [1,4,8].
Why Is aldehyde-lyase activity Important in Cell Biology?
GO:0016832 aldehyde-lyase activity matters because it governs rate-limiting carbon-carbon bond cleavage steps that produce bioactive aldehydes, ketones, steroid hormones, and sphingolipid intermediates, and because mutations in aldehyde-lyase enzymes cause human endocrine and immunological disease [1,2,5,6]. The activity is also a target for biotechnology, including production of volatile C6 aldehydes from plant hydroperoxides and cyanogenic compounds from hydroxynitrile lyases [4,8].
• Controls steroid hormone biosynthesis through 17alpha-hydroxylase/17,20-lyase (CYP17A1).
• Regulates sphingosine-1-phosphate levels and immune cell trafficking via SGPL1 [2,6].
• Loss of SGPL1 causes sphingosine phosphate lyase insufficiency syndrome, a primary immunodeficiency state.
• Reduced SGPL1 activity is associated with glomerular proteinuria, skin irritation, and platelet activation in models.
• Plant hydroperoxide lyase produces volatile C6 aldehydes important for flavor and defense.
• Hydroxynitrile lyase enables cyanogenesis and has renewed biotechnological interest.
• Aldehyde-lyase reactions are attractive targets for mechanism-based inhibitors.
• The activity links enzyme mechanism to endocrine, renal, immune, and plant metabolic phenotypes [1,2,4,5,6].
What Happens During aldehyde-lyase activity?
Substrate recognition and binding
In simple terms: The enzyme first grabs a molecule that has both an -OH group and a C=O group.
Aldehyde-lyase enzymes bind substrates that contain a hydroxyl group and a carbonyl group, positioning the reactive carbon-carbon bond for cleavage [1,4,8]. In steroidogenic CYP17A1, the substrate is a 17alpha-hydroxylated steroid, and the enzyme subsequently cleaves the C17-C20 bond to yield a C17 ketone and acetic acid. In sphingosine-1-phosphate lyase (SGPL1), the substrate is sphingosine-1-phosphate, and the enzyme cleaves the C-C bond adjacent to the phosphate-bearing carbon to generate a fatty aldehyde and ethanolamine phosphate [2,6].
Carbon-carbon bond cleavage
In simple terms: The enzyme snaps the carbon-carbon bond, splitting one molecule into two smaller ones.
The defining catalytic event of GO:0016832 is cleavage of a C-C bond in a hydroxylated carbonyl substrate to form two smaller molecules, each being an aldehyde or a ketone [1,4,8]. For CYP17A1, the 17,20-lyase reaction converts 17alpha-hydroxypregnenolone or 17alpha-hydroxyprogesterone into dehydroepiandrosterone or androstenedione plus acetic acid. For SGPL1, cleavage of sphingosine-1-phosphate yields a fatty aldehyde and ethanolamine phosphate, thereby removing a potent signaling lipid [2,6].
Product formation and release
In simple terms: After cutting, the enzyme releases the two aldehyde or ketone products.
Aldehyde-lyase reactions release two smaller products that are aldehydes or ketones [1,4,8]. In plants, hydroperoxide lyase converts hydroperoxy-fatty acids into volatile C6 aldehydes, which contribute to flavor and defense. Hydroxynitrile lyase releases hydrogen cyanide and an aldehyde or ketone from a cyanohydrin, supporting cyanogenesis. In steroidogenesis, the released C19 steroid products are androgens, while the C17 ketone product of the lyase step is a precursor for androgen biosynthesis.
Physiological context of the reaction
In simple terms: Where and when the enzyme acts determines its biological impact.
Aldehyde-lyase activity occurs in distinct physiological contexts: adrenal and gonadal steroidogenesis for CYP17A1, sphingolipid catabolism in immune and renal cells for SGPL1 [2,5,6], and plant oxylipin and cyanogenic pathways for hydroperoxide lyase and hydroxynitrile lyase [4,8]. In each context, the reaction controls the balance between signaling precursors and terminal products, which explains why loss-of-function mutations produce tissue-specific phenotypes [1,2,5,6].
Key Genes Involved in GO:0016832 aldehyde-lyase activity
The following genes and proteins represent experimentally characterized aldehyde-lyase enzymes and related factors across human, animal, and plant systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP17A1 | 17alpha-hydroxylase/17,20-lyase; cleaves C17-C20 bond in steroid intermediates | Steroid hormone biosynthesis and 17alpha-hydroxylase/17,20-lyase deficiency |
| SGPL1 | Sphingosine-1-phosphate lyase; cleaves sphingosine-1-phosphate to fatty aldehyde and ethanolamine phosphate | Sphingosine phosphate lyase insufficiency syndrome and immune regulation [2,6] |
| SGPL1 (AAV9 model) | Gene therapy target in lung fibrosis | AAV9-SGPL1 gene therapy in animal models |
| SGPL1 (podocyte) | Sphingosine-1-phosphate lyase activity in glomerular cells | Proteinuria, skin irritation, and platelet activation models |
| Hydroperoxide lyase (plant) | Converts hydroperoxy-fatty acids to volatile C6 aldehydes | Plant volatile aldehyde production and biotechnology |
| Hydroxynitrile lyase (plant) | Cleaves cyanohydrins to release HCN and aldehyde/ketone | Cyanogenesis and biotechnological applications |
| CYP17A1 (inhibitor studies) | Target of mechanism-based inhibitors | Pharmacological modulation of lyase activity |
| SGPL1 (inhibitor studies) | Target of sphingosine-1-phosphate lyase inhibitors | Efficacy and mechanism studies in disease models |
| CYP17A1 (deficiency models) | Loss-of-function causes steroidogenic defects | Endocrine disease modeling |
| SGPL1 (immunodeficiency) | Loss-of-function causes primary immunodeficiency | Immune cell development and function studies |
| SGPL1 (fibrosis) | Modulates lung fibrosis in animal models | Gene therapy and fibrosis research |
| SGPL1 (platelet) | Regulates platelet activation | Hemostasis and thrombosis research |
| SGPL1 (podocyte) | Maintains glomerular filtration barrier | Renal disease modeling |
| Hydroperoxide lyase (mint) | Produces C6 aldehydes from hydroperoxy-fatty acids | Plant biochemistry and flavor research |
| Hydroxynitrile lyase (plant) | Natural cyanogenic enzyme | Biocatalysis and cyanogenesis research |
| CYP17A1 (steroidogenesis) | Androgen precursor production | Reproductive endocrinology |
| SGPL1 (sphingolipid) | Sphingolipid catabolism | Lipid signaling research [2,6] |
| CYP17A1 (lyase step) | Rate-limiting androgen synthesis | Drug discovery and inhibitor design [1,7] |
How Is aldehyde-lyase activity Regulated?
Aldehyde-lyase activity is regulated at multiple levels. CYP17A1 lyase activity is influenced by substrate availability, redox partners, and post-translational modifications that favor the lyase versus hydroxylase reaction. SGPL1 activity is regulated by substrate availability and can be pharmacologically inhibited by mechanism-based inhibitors, which alters sphingosine-1-phosphate signaling [6,7]. In plants, hydroperoxide lyase activity is regulated by the availability of hydroperoxy-fatty acid substrates generated by lipoxygenase pathways. Hydroxynitrile lyase activity is regulated during cyanogenesis in response to tissue damage.
aldehyde-lyase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP17A1 | 17alpha-hydroxylase/17,20-lyase deficiency | Knockout or point-mutation cell models for steroidogenesis |
| SGPL1 | Sphingosine phosphate lyase insufficiency syndrome | Knockout and knock-in models in immune cells |
| SGPL1 | Lung fibrosis | AAV9-SGPL1 overexpression in animal models |
| SGPL1 | Proteinuria, skin irritation, platelet activation | Reduced-activity models in podocytes and platelets |
| SGPL1 | Sphingolipid signaling and immune regulation | Mechanism-based inhibitor studies [6,7] |
17alpha-hydroxylase/17,20-lyase deficiency
Defects in CYP17A1, which catalyzes the aldehyde-lyase step in steroidogenesis, cause 17alpha-hydroxylase/17,20-lyase deficiency, a disorder of steroid hormone biosynthesis. Loss of lyase activity impairs androgen production, leading to endocrine phenotypes that are studied using biochemical and genetic models.
Sphingosine phosphate lyase insufficiency syndrome
Biallelic loss-of-function variants in SGPL1 cause sphingosine phosphate lyase insufficiency syndrome, which presents as a primary immunodeficiency state with multi-system involvement. Reduced SGPL1 activity leads to accumulation of sphingosine-1-phosphate and is associated with glomerular proteinuria, skin irritation, and platelet activation in experimental models. Inhibiting SGPL1 has been explored for efficacy and mechanism in disease models.
Lung fibrosis and gene therapy
AAV9-SGPL1 gene therapy has been tested in an animal model of lung fibrosis, linking aldehyde-lyase activity to fibrotic tissue remodeling. This work supports the concept that restoring SGPL1 function can modify disease progression.
Biotechnological and plant disease relevance
Plant hydroperoxide lyase produces volatile C6 aldehydes that contribute to defense and flavor, while hydroxynitrile lyase supports cyanogenesis and has renewed biotechnological interest [4,8]. These activities are relevant to crop protection and industrial biocatalysis [4,8].
From aldehyde-lyase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CYP17A1 lyase activity impair androgen synthesis? | CYP17A1 knockout cell model |
| Does a specific CYP17A1 point mutation selectively abolish lyase activity? | Point-mutation knock-in cell model |
| Can SGPL1 restoration rescue fibrosis? | AAV9-SGPL1 overexpression in animal model |
| Does SGPL1 deficiency alter immune cell function? | SGPL1 knockout immune cell model |
| Can SGPL1 activity be monitored in living cells? | Tagged knock-in SGPL1 reporter [2,6] |
| Does pharmacological inhibition of SGPL1 reproduce disease phenotypes? | Mechanism-based inhibitor treatment in cell models [6,7] |
How to Study the aldehyde-lyase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic activity assay | Aldehyde or ketone product formation | Confirming aldehyde-lyase function [1,4] |
| CRISPR knockout | Loss-of-function phenotype | Testing causal role of aldehyde-lyase genes [1,2] |
| Point-mutation knock-in | Effect of specific residue changes | Dissecting catalytic mechanism |
| Overexpression | Gain-of-function or rescue | Gene therapy models |
| Lipid/steroid profiling | Substrate and product levels | Pathway flux analysis [1,2,6] |
| Inhibitor treatment | Enzyme inhibition and downstream effects | Mechanism and therapeutic studies [6,7] |
| Tagged knock-in imaging | Protein localization and dynamics | Live-cell studies [2,6] |
| Transcriptomics/proteomics | Expression changes in pathway genes | Systems-level analysis [2,5] |
Enzymatic activity assays
Aldehyde-lyase activity can be measured using substrate-specific assays that detect the formation of aldehyde or ketone products, as shown for CYP17A1 lyase activity and plant hydroperoxide lyase [1,4]. These assays are essential for confirming that a candidate gene encodes a functional aldehyde-lyase [1,4].
Genetic and CRISPR models
CRISPR knockout, point-mutation, and knock-in models allow causal testing of aldehyde-lyase genes in steroidogenesis, sphingolipid metabolism, and immune function [1,2,3,5]. Overexpression models, such as AAV9-SGPL1, can test rescue of disease phenotypes.
Lipid and steroid profiling
Mass spectrometry-based profiling of steroids and sphingolipids quantifies the products and substrates of aldehyde-lyase reactions, linking enzyme activity to pathway flux [1,2,6]. Such profiling is used to characterize disease models and inhibitor effects [1,2,6].
Inhibitor and mechanism studies
Mechanism-based inhibitors of SGPL1 and CYP17A1 are used to probe catalytic mechanism and to evaluate therapeutic potential [6,7]. These studies help distinguish lyase activity from related enzymatic activities [6,7].
How CRISPR Can Be Used to Study GO:0016832 aldehyde-lyase activity
Knockout
CRISPR knockout of aldehyde-lyase genes such as CYP17A1 or SGPL1 creates loss-of-function cell models to test effects on steroidogenesis, sphingolipid metabolism, and immune function [1,2,5]. These models are foundational for linking GO:0016832 activity to disease phenotypes [1,2,5].
Point Mutation
Point-mutation knock-in models introduce specific amino acid substitutions to dissect catalytic residues and to mimic patient variants in aldehyde-lyase genes [1,2]. Such models help distinguish lyase-specific defects from broader enzyme dysfunction [1,2].
Knock-in
Tagged knock-in of aldehyde-lyase genes enables tracking of protein localization, stability, and interaction partners in live cells [2,6]. Knock-in of disease-associated variants supports genotype-phenotype studies [1,2].
Overexpression
Overexpression of aldehyde-lyase genes, such as AAV9-SGPL1, can rescue disease phenotypes in animal models and is used to test therapeutic potential. Overexpression also helps define downstream pathway effects.
How EDITGENE Supports aldehyde-lyase activity Research
Researchers studying aldehyde-lyase activity-related genes often need to determine whether a candidate gene is causally involved in a specific pathway or disease, and whether a particular mutation alters catalytic function. EDITGENE provides CRISPR-based cell models and screening services to answer these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for aldehyde-lyase activity research.
Frequently Asked Questions About aldehyde-lyase activity
What is aldehyde-lyase activity?
Aldehyde-lyase activity (GO:0016832) is the catalysis of C-C bond cleavage in a molecule containing a hydroxyl group and a carbonyl group to form two smaller aldehyde or ketone products [1,4,8].
What genes are involved in aldehyde-lyase activity?
Key genes include CYP17A1, SGPL1, plant hydroperoxide lyase, and hydroxynitrile lyase [1,2,4,8].
What is the synonym for GO:0016832?
The synonym is aldolase activity [1,4].
Which diseases are linked to aldehyde-lyase activity?
17alpha-hydroxylase/17,20-lyase deficiency and sphingosine phosphate lyase insufficiency syndrome are linked to defects in aldehyde-lyase enzymes [1,2].
How is aldehyde-lyase activity measured?
It is measured by enzymatic assays detecting aldehyde or ketone product formation, often combined with lipid or steroid profiling [1,4,6].
What is the role of SGPL1 in immunity?
SGPL1 loss causes sphingosine phosphate lyase insufficiency syndrome, a primary immunodeficiency state.
Can CRISPR be used to study aldehyde-lyase genes?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are used to test causal roles of aldehyde-lyase genes [1,2,3,5].
What is the role of CYP17A1 lyase activity?
CYP17A1 lyase activity cleaves the C17-C20 bond in steroid intermediates to produce androgen precursors.
Are there inhibitors of aldehyde-lyase enzymes?
Mechanism-based inhibitors have been developed for SGPL1 and studied for CYP17A1 [6,7].
Why is aldehyde-lyase activity important in plants?
Plant hydroperoxide lyase produces volatile C6 aldehydes, and hydroxynitrile lyase supports cyanogenesis and biocatalysis [4,8].
Conclusion
GO:0016832 aldehyde-lyase activity defines a fundamental carbon-carbon cleavage reaction that produces aldehyde or ketone products and operates in steroidogenesis, sphingolipid metabolism, plant oxylipin pathways, and cyanogenesis [1,2,4,8]. Its dysfunction is linked to endocrine and immunological disease, making it a compelling target for mechanistic and therapeutic research [1,2,5,6]. CRISPR-based models and biochemical assays provide the tools needed to dissect aldehyde-lyase function and to translate findings into disease and biotechnology applications [1,2,3,5,6,7].
References
- 1. Yanase T. 1995. 17 alpha-Hydroxylase/17,20-lyase defects.. J Steroid Biochem Mol Biol 53(1-6):153-7 PMID: 7626447
- 2. Gharagozlou S et al.. 2024. Sphingosine phosphate lyase insufficiency syndrome as a primary immunodeficiency state.. Adv Biol Regul 94:101058 PMID: 39454238
- 3. Bhattacharyya A et al.. 2024. Gene therapy with AAV9-SGPL1 in an animal model of lung fibrosis.. J Pathol 263(1):22-31 PMID: 38332723
- 4. Gargouri M et al.. 2004. Hydroperoxide-lyase activity in mint leaves. Volatile C6-aldehyde production from hydroperoxy-fatty acids.. J Biotechnol 111(1):59-65 PMID: 15196770
- 5. Schümann J et al.. 2015. Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation.. Toxicol Pathol 43(5):694-703 PMID: 25630683
- 6. George N et al.. 2024. Inhibiting sphingosine 1-phosphate lyase: From efficacy to mechanism.. Neurobiol Dis 199:106585 PMID: 38955289
- 7. Pons G et al.. 2020. A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor.. J Org Chem 85(2):419-429 PMID: 31860798
- 8. Kassim MA et al.. 2014. HCN production and hydroxynitrile lyase: a natural activity in plants and a renewed biotechnological interest.. Biotechnol Lett 36(2):223-8 PMID: 24062137
